Skip to main content
logo
BioLight Life Sciences Ltd. (TLV:BOLT)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
370.60
+23.00 (6.62%)
Aug 3, 2026, 5:24 PM IDT

BioLight Life Sciences Financials Overview

Millions ILS. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
--0.220.120.060
Revenue Growth
--85.59%87.30%2000.00%-90.32%
Gross Profit
--0.220.120.060
Operating Income
-15.21-15.21-10.12-10.65-10.32-10.6
Net Income
-11.73-11.73-7.14-26.02-7.850.38
Earnings Per Share
-1.98-1.98-1.53-5.60-1.720.08
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
22.4422.4413.478.6417.6333.71
Total Debt
0.770.770.60.090.530.44
Net Cash (Debt)
21.6721.6712.878.5517.133.27
Net Cash Growth
68.41%68.41%50.47%-49.98%-48.61%-33.70%
Net Cash Per Share
3.663.662.761.843.747.25

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-10.85-10.85-10.99-9.58-9.47-10
Capital Expenditures
-0.01-0.01-0.03-1.42-0.1-0.63
Free Cash Flow
-10.86-10.86-11.02-10.99-9.57-10.63
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
--100.00%100.00%100.00%100.00%
Operating Margin
---4619.64%-9026.27%-16384.13%-353433.33%
Pretax Margin
---3846.58%-23294.07%-13788.89%-63700.00%
Profit Margin
---3261.19%-22050.85%-12455.56%12733.33%
FCF Margin
---5032.88%-9315.25%-15193.65%-354333.33%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-----137.74
PS Ratio
--115.64204.41478.5417539.14